• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 6
      Transcatheter Tricuspid Valve Replacement With the Novel System: 1-Year Outcomes From the TRAVEL Study - 3 month(s) ago

      AbstractBackgroundTranscatheter tricuspid valve replacement (TTVR) is emerging as a promising surgical alternative for high-risk patients with tricuspid regurgitation (TR). Nonetheless, the feasibi…

      Source: www.jacc.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        Todavía tratamos muy pocos pacientes con insuficiencia tricuspidea en 🇦🇷 https://t.co/WX9tSQilxa https://t.co/94Zkj2lm5C

    • Mashup Score: 0
      Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial - 3 month(s) ago

      The angiography-derived FFR-guided comprehensive PCI strategy, encompassing revascularisation decision making and stent optimisation, was non-inferior to intravascular ultrasound guidance. This finding might have implications for future guidelines on its role and application.

      Source: www.thelancet.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        Angiography-derived FFR vs IVUS guided PCI. Which would be your choice in case you cannot use both ? https://t.co/bUQsv4Jq5Z https://t.co/VAw8YmkMmx

    • Mashup Score: 2
      TAVI or TAVR: it is time to use a single standardized acronym for percutaneous aortic valve implantation - 4 month(s) ago

      The percutaneous aortic valve implantation, introduced in 2002 by Alain Cribier1 in Rouen, France, has revolutionized the treatment of aortic stenosis as i

      Source: academic.oup.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        #TAVR or #TAVI which acronym do you use?? https://t.co/JVKGmgX2tp

    • Mashup Score: 2
      Comparison of strategies for vascular ACCESS closure after Transcatheter Aortic Valve Implantation: the ACCESS-TAVI randomized trial - 5 month(s) ago

      AbstractBackground and Aims. Data from randomized trials investigating different access closure strategies after transfemoral transcatheter aortic valve im

      Source: academic.oup.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        Our default strategy suture/plug-based closure for TF-TAVI. For EVAR main access many times we use 2sutures+1 Plug https://t.co/mxB3NrDjgm https://t.co/BkwL7Ooamb

    • Mashup Score: 5
      Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study - 5 month(s) ago

      AbstractBackground and Aims. Frailty is increasingly prevalent in people presenting with acute coronary syndrome (ACS). This high-risk group is typically e

      Source: academic.oup.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        Beneficios de la revasc. en Ptes con fragilidad 👵🏽🧑🏾‍🦯‍➡️👨🏾‍🦽‍➡️Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study | European Heart Journal | Oxford Academic https://t.co/HetZ6GkTo6

    • Mashup Score: 3
      Weekend effect on in-hospital outcomes of transcatheter aortic valve replacement: insights from a propensity-matched national analysis - BMC Cardiovascular Disorders - 5 month(s) ago

      Background The “weekend effect” on hospital admissions has been extensively studied, showing increased risks for patients admitted on weekends than those admitted on weekdays. We aimed to assess the “weekend effect” on in-hospital outcomes in patients undergoing transcatheter aortic valve replacement (TAVR). Methods A nationwide cohort study was conducted using the National Inpatient Sample Database. We identified 82,094 eligible patients aged ≥ 18 years admitted for TAVR between 2013 and 2021. Patients were grouped into weekend or weekday cohorts based on day of admission. Propensity score matching (PSM) and multivariate regression models were employed to evaluate outcomes. After PSM, 2,688 weekend admissions and 13,440 weekday admissions were included in the analyses. Results Multivariable regression, adjusted for propensity score, revealed that weekend admission was associated with 45% higher odds of in-hospital mortality (adjusted odds ratio: 1.45; 95% confidence interval: 1.13–1.8

      Source: bmccardiovascdisord.biomedcentral.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        Weekend effect on in-hospital outcomes of transcatheter aortic valve replacement: insights from a propensity-matched national analysis | BMC Cardiovascular Disorders | Full Text https://t.co/yM8fwBoL98

    • Mashup Score: 7
      Diabetes is associated with a higher incidence of short-term mortality risk and readmission in patients who undergo surgical but not transcatheter aortic valve replacement - 5 month(s) ago

      Background Transcatheter aortic valve replacement (TAVR) is increasingly used for aortic valve replacement instead of surgical aortic valve replacement (sAVR). We aimed to examine the impact of diabetes on 30-day mortality, 30-day readmission and compare outcomes between TAVR and sAVR.Methods Data were extracted from the Nationwide Readmissions Database from 2012 to 2017. The primary outcome was 30-day mortality, and the secondary outcome was 30-day readmission.Results The study included 110 135 patients who underwent aortic valve replacement. Of these, 59 466 (54.0%) were hospitalised for TAVR, and 50 669 (46.0%) underwent sAVR. Diabetes was present in 36.4% of TAVR patients and 29.1% of sAVR patients. In TAVR patients, the adjusted risk of 30-day readmission and mortality was similar regardless of diabetes status (aHR=0.94 (0.86–1.03); 0.97 (0.84–1.12); respectively). However, sAVR patients with diabetes had a higher adjusted risk of 30-day mortality (aHR=1.13 (1.01–1.25)) but not re

      Source: openheart.bmj.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        Would be #DBT anindication for #TAVR over #SAVR?! Diabetes is associated with a higher incidence of short-term mortality risk and readmission in patients who undergo surgical but not transcatheter aortic valve replacement | Open Heart https://t.co/5UEFZok7mp

    • Mashup Score: 14
      FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs | Circulation: Cardiovascular Interventions - 5 month(s) ago

      BACKGROUND: Despite fractional flow reserve (FFR)–guided deferral of revascularization, recurrent events in patients with diabetes or after myocardial infarction remain common. This study aimed to assess the association between FFR-negative but high-risk nonculprit lesions and clinical outcomes. METHODS: This is a patient-level pooled analysis of the prospective natural-history COMBINE (OCT-FFR) study (Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients) and PECTUS-obs study (Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI Patients With Residual Non- Flow Limiting Lesions). Optical coherence tomography was performed on all FFR-negative (FFR >0.80) native nonculprit lesions. Patients or lesions with a high-risk plaque were compared with those without a high-risk plaque. A high-risk plaque was defined in the presence of at least 2 prespecified criteria: (1) lipid arc ≥90o, (2) minimum fibrous

      Source: www.ahajournals.org
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs | Circulation: Cardiovascular Interventions https://t.co/N17kNK7DVb

    • Mashup Score: 13
      FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs | Circulation: Cardiovascular Interventions - 5 month(s) ago

      BACKGROUND: Despite fractional flow reserve (FFR)–guided deferral of revascularization, recurrent events in patients with diabetes or after myocardial infarction remain common. This study aimed to assess the association between FFR-negative but high-risk nonculprit lesions and clinical outcomes. METHODS: This is a patient-level pooled analysis of the prospective natural-history COMBINE (OCT-FFR) study (Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients) and PECTUS-obs study (Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI Patients With Residual Non- Flow Limiting Lesions). Optical coherence tomography was performed on all FFR-negative (FFR >0.80) native nonculprit lesions. Patients or lesions with a high-risk plaque were compared with those without a high-risk plaque. A high-risk plaque was defined in the presence of at least 2 prespecified criteria: (1) lipid arc ≥90o, (2) minimum fibrous

      Source: www.ahajournals.org
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs | Circulation: Cardiovascular Interventions https://t.co/N17kNK7DVb

    • Mashup Score: 2
      Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results | Circulation: Cardiovascular Interventions - 5 month(s) ago

      BACKGROUND: Evidence is limited as to whether outcomes differ between patients with tricuspid regurgitation (TR) treated with tricuspid transcatheter edge-to-edge repair (T-TEER) versus surgical tricuspid valve repair. We aimed to compare outcomes between these 2 approaches. METHODS: We analyzed the data on Medicare fee-for-service beneficiaries aged 65 to 99 years with TR who underwent T-TEER or isolated surgical repair between July 2016 and December 2020. The primary outcome was 2-year all-cause mortality. Other outcomes included in-hospital mortality and permanent pacemaker implantation as well as 2-year heart failure hospitalization and tricuspid valve reintervention. A propensity score matching weight analysis was used to adjust for potential confounders. RESULTS: A total of 1143 patients were included (409 T-TEER versus 734 surgery). The proportion of T-TEER cases increased from 2% in the third quarter of 2016 to 67% in the last quarter of 2020 among all isolated TR procedures. A

      Source: www.ahajournals.org
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	omendiz
        omendiz

        Transcatheter Vs Surgical Tricuspid Repair Among Patients With TR: Two-Year Results Circulation Cardiovascular: Mortality rate was comparable between T-TEER and surgical repair T-TEER showed ⬇️ in-hospital mortality & PPMI rates but ⬆️reinterventions https://t.co/Odqd8JhjMj

    Load More

    Oscar Mendiz

    @omendiz

    Interventional Cardiologist. Director ICyCC Fundación Favaloro. Cardiology and Soccer Fan. Fanático del CAI. Tweets=muy opinion. Instagram @oamendiz

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings